52238-35-4
52238-35-4 結(jié)構(gòu)式
基本信息
中文別名
化合物 T102009-羥基玫瑰樹堿鹽酸鹽
9-HYDROXYELLIPTICINE 鹽酸
英文別名
Nsc2641369-hydroxyellipticine HCl salt
9-Hydroxyellipticine, Hydrochloride
物理化學性質(zhì)
熔點>223oC (dec.)
儲存條件Hygroscopic, -20°C Freezer, Under inert atmosphere
溶解度DMSO (Slightly, Heated), Methanol (Slightly, Sonicated)
形態(tài)Solid
顏色Orange to Dark Orange
Nsc264136價格(試劑級)
| 報價日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
| 2026/06/05 | HY-101775A | 9-Hydroxyellipticine hydrochloride | 52238-35-4 | 1 mg | 670元 |
常見問題列表
生物活性
9-Hydroxyellipticine hydrochloride 是 Topo II 和RyR 的抑制劑。9-Hydroxyellipticine hydrochloride 具有抗腫瘤、抗氧化和釋放兒茶酚胺的活性。 9-Hydroxyellipticine hydrochloride 對 Hela S-3 和293T 細胞的IC50 值分別為1.6 μM 和1.2μM。靶點
|
Topoisomerase II
|
體外研究
9-Hydroxyellipticine (9HE) causes selective inhibition of p53 protein phospborylation in Lewis lung carcinoma and SW480 (human colon cancer cell line) in a concentration-dependent manner from 0.1 to 100 μM.
體內(nèi)研究
9-Hydroxyellipticine (5 or 10 mg/kg, ip) results in chromosome clumping and sister chromatid exchange in murine bone marrow cells.
| Animal Model: | Three- to five-month-old C57B1/6 male mice. |
| Dosage: | 5 or 10 mg/kg. |
| Administration: | IP. |
| Result: | Resulted in chromosome clumping, chromatid aberrations, and micronuclei formation in murine bone marrow cells. |